HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,874,000 | +49.0% | 69,917 | 0.0% | 0.07% | +24.6% |
| Q1 2020 | $1,258,000 | -51.5% | 69,917 | -65.0% | 0.06% | -43.0% |
| Q1 2017 | $2,592,000 | +31.2% | 200,000 | 0.0% | 0.10% | +19.0% |
| Q4 2016 | $1,976,000 | -18.2% | 200,000 | 0.0% | 0.08% | -9.7% |
| Q3 2016 | $2,416,000 | +40.0% | 200,000 | 0.0% | 0.09% | +32.9% |
| Q2 2016 | $1,726,000 | -8.9% | 200,000 | 0.0% | 0.07% | -13.6% |
| Q1 2016 | $1,894,000 | -45.4% | 200,000 | 0.0% | 0.08% | -35.7% |
| Q4 2015 | $3,466,000 | – | 200,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |